CD2AP and Alzheimer disease: In a large, prospective cohort study, Juul Rasmussen et al. investigated the association between a genetic risk score created using PICALM, BIN1, CD2AP, and RIN3 and a risk of Alzheimer’s disease and they found that the risk score was associated with a higher risk [151].